Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates in three segments: Diagnostic Testing Services, Imaging Services, and Others. The company conducts various medical diagnostic tests and profiles of tests that focuses on early detection and management of disorders and diseases, including thyroid, growth, metabolism, auto-immunity, diabetes, anaemia, cardiovascular, infertility, COVID, and various infectious diseases. Its profiles of tests include profiles of tests administered under its Aarogyam brand, which offers patients a suite of wellness and preventive health care tests. The company sells glucometer and glucostrips under the brand name Sugarscan; consumables; and radiopharmaceutical. Thyrocare Technologies Limited was founded in 1996 and is based in Navi Mumbai, India. Thyrocare Technologies Limited is a subsidiary of Docon Technologies Private Limited.
Stock data | 2023 | Change |
---|---|---|
Price | $10.34 | N/A |
Market Cap | $547.38M | N/A |
Shares Outstanding | 52.92M | 0.06% |
Employees | 1.65K | N/A |
Shareholder Equity | 5.35B | 1.64% |
Valuation | 2023 | Change |
---|---|---|
P/E Ratio | 0.85 | N/A |
P/S Ratio | 8.73 | N/A |
P/B Ratio | 0.10 | N/A |
Growth | 2023 | Change |
---|---|---|
Return on Equity | 0.0014 | N/A |
Earnings | 2023 | Change |
---|---|---|
Revenue | $62.71M | N/A |
Earnings | $7.66M | N/A |
EPS | 12.14 | N/A |
Earnings Yield | 1.17 | N/A |
Gross Margin | 0.6901 | N/A |
Operating Margin | 0.1607 | N/A |
Net income margin | 0.1222 | N/A |
Financial Strength | 2023 | Change |
---|---|---|
Total Assets | $75.34M | N/A |
Total Debt | $2.78M | N/A |
Cash on Hand | $16.68M | N/A |
Debt to Equity | 0.0022 | 18.29% |
Cash to Debt | $6.01 | -10.41% |
Current Ratio | $3.54 | -15.41% |